Showing results (11-20 of 39) with videos related to

Sort By:
Pageof 4
Bjpsych Open|February 14, 2023
Response to electroconvulsive therapy in treatment-resistant depression: nationwide observational follow-up studyAdam Nygren, Johan Reutfors, Lena Brandt, et al.
Synapse (New York, N.Y.)|July 4, 2014
No correlation between serotonin and its metabolite 5-HIAA in the cerebrospinal fluid and [(11) C]AZ10419369 binding measured with PET in healthy volunteersMikael Tiger, Per Svenningsson, Magdalena Nord, et al.
Bjpsych Open|March 23, 2021
The effect of anaesthetic dose on response and remission in electroconvulsive therapy for major depressive disorder: nationwide register-based cohort studyAlexander Kronsell, Axel Nordenskjöld, Max Bell, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|July 12, 2022
In vivo correlation of serotonin transporter and 1B receptor availability in the human brain: a PET studyJonas E Svensson, Mikael Tiger, Pontus Plavén-Sigray, et al.
International Journal of Psychiatry in Clinical Practice|December 1, 2021
Health care utilisation in treatment-resistant depression: a Swedish population-based cohort studyPhilip Brenner, Adam Nygren, David Hägg, et al.
Frontiers in Neuroscience|August 6, 2021
Plasma Levels of Brain-Derived Neurotrophic Factor and S100B in Relation to Antidepressant Response to KetamineHaitang Jiang, Emma R Veldman, Mikael Tiger, et al.
Translational Psychiatry|June 2, 2020
A randomized placebo-controlled PET study of ketamine´s effect on serotonin<sub>1B</sub> receptor binding in patients with SSRI-resistant depressionMikael Tiger, Emma R Veldman, Carl-Johan Ekman, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|February 9, 2026
Quantification of pituitary 5-HT<sub>1B</sub> receptors with positron emission tomography: Negligible specific binding despite conspicuous uptakeMartin Gärde, Katarina Varnäs, Johan Lundberg, et al.
Translational Psychiatry|November 19, 2025
Real-world analysis of pharmacological treatments to prevent relapse after electroconvulsive therapy for major depressive disorder: A nationwide cohort studyAlexander Kronsell, Axel Nordenskjöld, Robert Bodén, et al.
Journal of Affective Disorders|May 19, 2021
P11 (S100A10) as a potential predictor of ketamine response in patients with SSRI-resistant depressionEmma R Veldman, Dejan Mamula, Haitang Jiang, et al.
Pageof 4